| abstract |
There is provided a compound having the formula (I), or a pharmaceutically acceptable salt, hydrate or N-oxide thereof, useful for treating a disease which binds to CXCR7 and is dependent at least in part on CXCR7 activity: Accordingly, the present invention provides, in a further aspect, a composition containing one or more of the above-described compounds together with a pharmaceutically acceptable excipient. |